Nelson Fernandes, CerTest Biotec, on Diagnostic Products
We caught up with Nelson Fernandes, the Managing Director at CerTest Biotec, at 33rd ECCMID as he discusses his company’s diagnostic and molecular biology products. He explains that CerTest Biotec specializes in the development of rapid diagnostic tests for infectious diseases, including COVID-19.
Fernandes highlights some of the company’s other key products, such as CerTec’s raw materials and Pharma products.
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more